Simoctocog Alfa

3 trials 3 recruiting BHaematology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

3 Recruiting

0 Completed trials

3 Sponsors

10 Countries

Phase IV

Phase IV: 3

Sponsors using this IMP

Octapharma AG 2 Emory University 1 HZRM Haemophilie-Zentrum Rhein Main GmbH 1

All trials

3 total

Nuwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-l… Recruiting

2022-502061-17-00 Phase IV 6 countries Octapharma AG
Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER) Recruiting

2022-502060-21-00 Phase IV 6 countries Octapharma AG
An international investigator initiated trial to capture different approaches in the treatment of Haemophilia A Patients With FVIII Inhibito… Recruiting

2024-516741-39-00 Phase IV 7 countries Emory University; HZRM Haemophilie-Zentrum Rhein Main GmbH

Showing 1–3 of 3 trials

← All drugs A–Z